NAD+ NEURO NUTRIENT, BEST IV!
- Jan 8, 2022
- 1 min read
Updated: Aug 1, 2022
OUR CLOSEST INFUSION COMPETITOR USES A WEAK & SUBSTANDARD FORMULAS:
COMPETITOR HAS ONLY 5 AMINO ACIDS TWO OF WHICH ARE THE SAME!
D2DR NEURORECEPTORS HAVE 16 PARIRED AMINO ACIDS NEEDED TO BE REPAIRED!
COMPETITOR ONLY USES LOW DOSE NAD+ AT 250MG-500MG!
NAD+ IS SHOWN TO ONLY WORK OPTIMALLY AT 600MG-1200MG PER INFUSION!
COMPETITOR USES MYERS COCKTAIL WHICH WORKS WELL BUT CAN NOT BILL!
MORE CO-FACTORS ARE NEEDED WITH BALANCED CO-ENZYMES & ELECTROLYTES!
COMPETITORS DONT USE PRE & POST TEST IMAGING TO PROVE THEIR RESULTS!
ITS A NO BRAINER THAT IF YOU BELIEVE YOUR PRODUCT WORKS THEN PROVIDE INDEPENDENTLY VALIDATED PROOF THAT IT DOE WORK!
OUR NAD+ NEURO NEUTRIENT INFUSION FORMULA RESTORITROL HAS 45 REQUIRED INTRACELLUALR, NATURALLY OCCURING NEURO SPECIFIC
ELEMENTS & COMPOUNDS TO FULLY REPAIR, RESTORE, REBALANCE & REGENERATE CELLS, TISSUES & ORGANS SYSTEMS!
You have to know your target and what to replace to repair, restore and regenerate the target.
D2DR Addiction Target is what we study and treat to speed up the biological repair of the addiction mechanism:
DOPAMINE REWARD CASCADE
THE DEVELOPMENT OF PRECISION ADDICTION MANAGEMENT Blum et al. proposed that KB220Z; a mild neuro-nutrient formulation, can stimulate the D2 receptor (29). Blum’s group advocates instigating dopamine release, to cause the induction of D2-directed mRNA to direct the proliferation of D2 receptors in the brain (30). For example, DNA-directed compensatory overexpression of the DRD2 receptors (a form of gene therapy), resulted in a significant reduction in alcohol craving behavior in alcohol-preferring rodents (31) and self-administration of cocaine (32). Thus, based on this model enhanced bioavailability of D2 receptors was shown to reduce craving. Studies that showed rats with depleted neostriatal dopamine display increased sensitivity to dopamine agonists estimated to be 30–100 x in the 6-hydroxydopamine (6-OHDA) rotational model (33) were…